This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Nebius Reaffirms $2B Capex for 2025: Enough to Fuel Expansion?
by Zacks Equity Research
NBIS reaffirms $2 billion 2025 capex, doubling down on AI infrastructure growth while rivals ramp up massive spending of their own.
CoreWeave Rises 25% in a Month: Is There More Room for Growth?
by Vaishali Doshi
CRWV surges 25% in a month on soaring AI demand, but steep capex and leverage cloud the outlook.
NBIS Stock Surges 25% in a Month: Stay Invested or Book Profits?
by Vaishali Doshi
Nebius stock has soared 25% in a month on a $17.4B Microsoft deal and surging AI demand, but risks loom amid heavy capex and fierce competition.
Zacks Investment Ideas feature highlights: Nebius Group, Meta, Microsoft, Alphabet and Nvidia
by Zacks Equity Research
Nebius lands a $17.4B Microsoft deal, sending shares surging 50% as its Nvidia-backed AI infrastructure model gains momentum.
FOMC Looms: 'Irrational Exhuberance' 2.0?
by Andrew Rocco
No matter the outcome of Wednesday's meeting, all signs point to one of the most pivotal FOMC meetings in recent memory. While a 25-bps cut appears baked in, the potential for market volatility is elevated.
Unlock Momentum with the Rare, Powerful High-Tight Flag Pattern
by Andrew Rocco
The high-tight flag is the rarest and most powerful technical chart pattern. By studying historical examples, investors can prepare to catch the next life-changing price advances.
Nosebleed Valuation: Why Nebius's Microsoft Deal Changes Everything
by Andrew Rocco
With its vertically integrated model, strategic Nvidia partnership, and the recently announced, game-changing contract with Microsoft, Nebius Group has positioned itself as a formidable leader in the AI industry.
Can CoreWeave's Ventures Initiative Boost its AI Ecosystem Growth?
by Shivangi Deora
CRWV launches Ventures to fuel AI's next frontier, backing startups with funding, compute power and strategic support.
Wall Street Week in Review: Stocks Notch Highs Despite Pessimism
by Andrew Rocco
It was a busy week on Wall Street marked by Oracle earnings, and a slew of individual news items. Looking ahead, all eyes will be on the Fed's interest-rate decision next week.
Market's Up, Inflation Tame: AI, Tech, & Small Caps Lead
by Andrew Rocco
Bulls remain in control of the market in the short-term, and the price action is telling them to stay long for now. While investors should continue to be vigilent about seasonality and a potential post-FOMC pullback, price remains king.
Beyond EVs: How Tesla Energy will Power the Next Growth Phase
by Andrew Rocco
While a slowing EV market has created short-term investor doubts, Tesla's underrated energy division is on fire its robotaxi business will scale quickly and its Optimus robot will move to mass production early next year.
Jobs Data Mess & AI's Moment: Unpacking the Week's Biggest News
by Andrew Rocco
Following a significant jobs revision that signals an weaker economy than previously thought, the AI industry's growth has become even more impressive. Recent news from Nebius and Oracle debunks key criticisms of the AI boom.
The Zacks Analyst Blog Highlights Nebius, Microsoft, UnitedHealth, Apple and Oracle
by Zacks Equity Research
Nebius, Microsoft, UnitedHealth, Apple, and Oracle drive market buzz as AI deals, Medicare gains, and cloud growth shake up stocks.
What's Going On With Nebius Shares?
by Derek Lewis
The market reacted ferociously to the Nebius and Microsoft news, with NBIS shares seeing a 50% surge the following day and reaching new all-time highs.
Oracle Misses in Q3, Gains +22% - Plus Jobs Revisions & More
by Mark Vickery
While Oracle missed on Q3 revenues it grew +55% in Cloud Infrastructure year over year.
Can Nebius Become the Next Big AI Player With $17.4B Microsoft Deal?
by Shreya Majumder
NBIS lands a $17.4B AI infrastructure deal with Microsoft, fueling growth, financing power, and marking a stronger edge in the cloud race.
CoreWeave to Acquire OpenPipe: Will the Buyout Strategy Be the Winning Play?
by Shreya Majumder
CRWV expands its AI toolkit with the OpenPipe buy, strengthening reinforcement learning capabilities and deepening vertical integration.
CRWV Witnesses Healthy Growth Across Healthcare and Finance Sectors
by Zacks Equity Research
CoreWeave raises 2025 revenue outlook as $30.1B backlog and surging AI cloud adoption drive growth across key industries.
CRWV vs. NBIS: Which AI Infrastructure Stock is the Smarter Buy Now?
by Vaishali Doshi
CRWV's scale, partnerships, and client wins position it ahead of NBIS in the AI infrastructure race, despite high leverage risks.
CoreWeave's Upbeat Outlook: Are Expanding Data Centers at the Core?
by Shreya Majumder
: CRWV lifts 2025 revenue outlook again as data center expansion, strong demand and new contracts fuel rapid growth.
CoreWeave Raises $25B Capital: Fuel for Growth or Leverage Trouble?
by Vaishali Doshi
CRWV has raised $25 billion through debt and equity to fuel data center investments, but soaring interest costs test its profitability.
Will Nebius' 1 GW Capacity Target by 2026 Accelerate Revenue Growth?
by Zacks Equity Research
NBIS boosts ARR outlook to $1.1 billion as it scales data-center capacity. It is targeting 1 GW by 2026 to capture AI-infrastructure demand.
Globant Q2 Earnings & Revenues Beat Estimates, Stock Down
by Zacks Equity Research
GLOB beats Q2 estimates with record pipeline growth, but shares fall 15% as 2025 guidance is trimmed.
CRWV Stock Crashes Post Q2 Earnings: Stay Invested or Make an Exit?
by Vaishali Doshi
CoreWeave shares tumble 33% despite record Q2 revenues, as high leverage, soaring capex, and profit pressures weigh on sentiment.
Globant (GLOB) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Globant (GLOB) delivered earnings and revenue surprises of +0.66% and +0.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?